Department of Medicine and Aging Sciences, University of Chieti-Pescara, Pescara, Italy.
Department of Oncology Hematology, Pescara Hospital, Pescara, Italy.
Biol Blood Marrow Transplant. 2020 Dec;26(12):2204-2210. doi: 10.1016/j.bbmt.2020.08.034. Epub 2020 Sep 19.
In the setting of T cell-depleted, full-haplotype mismatched transplantation, adoptive immunotherapy with regulatory T cells (Tregs) and conventional T cells (Tcons) can prevent graft-versus-host disease (GVHD) and improve post-transplantation immunologic reconstitution and is associated with a powerful graft-versus-leukemia effect. To improve the purity and the quantity of the infused Tregs, good manufacturing practices (GMP)-compatible expansion protocols are needed. Here we expanded Tregs using an automated, clinical-grade protocol. Cells were extensively characterized in vitro, and their efficiency was tested in vivo in a mouse model. Tregs were selected by CliniMacs (CD4CD25, 94.5 ± 6.3%; FoxP3, 63.7 ± 11.5%; CD127, 20 ± 3%; suppressive activity, 60 ± 7%), and an aliquot of 100 × 10 was expanded for 14 days using the CliniMACS Prodigy System, obtaining 684 ± 279 × 10 cells (CD4CD25, 99.6 ± 0.2%; FoxP3, 82 ± 8%; CD127, 1.1 ± 0.8%; suppressive activity, 75 ± 12%). CD39 and CTLA4 expression levels increased from 22.4 ± 12% to 58.1 ± 13.3% (P < .05) and from 20.4 ± 6.7% to 85.4 ± 9.8% (P < .01), respectively. TIM3 levels increased from .4 ± .05% to 29 ± 16% (P < .05). Memory Tregs were the prevalent population, whereas naive Tregs almost disappeared at the end of the culture. mRNA analysis displayed significant increases in CD39, IL-10, granzyme B, and IL-35 levels at the end of culture period (P < .05). Conversely, IFNγ expression decreased significantly by day +14. Expanded Tregs were sorted according to TIM3, CD39, and CD62L expression levels (purity >95%). When sorted populations were analyzed, TIM3 cells showed significant increases in IL-10 and granzyme B (P < .01) .When expanded Tregs were infused in an NSG murine model, mice that received Tcons only died of GVHD, whereas mice that received both Tcons and Tregs survived without GVHD. GMP grade expanded cells that display phenotypic and functional Treg characteristics can be obtained using a fully automated system. Treg suppression is mediated by multiple overlapping mechanisms (eg, CTLA-4, CD39, IL-10, IL-35, TGF-β, granzyme B). TIM3 cells emerge as a potentially highly suppressive population. © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
在 T 细胞耗竭、全单倍型匹配移植的背景下,采用调节性 T 细胞(Tregs)和常规 T 细胞(Tcons)的过继免疫疗法可以预防移植物抗宿主病(GVHD),并改善移植后的免疫重建,同时具有强大的移植物抗白血病效应。为了提高输注 Tregs 的纯度和数量,需要使用符合良好生产规范(GMP)的扩增方案。在这里,我们使用自动化的临床级方案来扩增 Tregs。细胞在体外进行了广泛的表征,并在小鼠模型中进行了体内测试。Tregs 通过 CliniMacs(CD4CD25,94.5 ± 6.3%;FoxP3,63.7 ± 11.5%;CD127,20 ± 3%;抑制活性,60 ± 7%)进行选择,并使用 CliniMACS Prodigy 系统在 14 天内扩增 100×10 个细胞,获得 684 ± 279×10 个细胞(CD4CD25,99.6 ± 0.2%;FoxP3,82 ± 8%;CD127,1.1 ± 0.8%;抑制活性,75 ± 12%)。CD39 和 CTLA4 的表达水平分别从 22.4 ± 12%增加到 58.1 ± 13.3%(P<.05)和 20.4 ± 6.7%增加到 85.4 ± 9.8%(P<.01)。TIM3 水平从.4 ±.05%增加到 29 ± 16%(P<.05)。记忆性 Tregs 是主要的群体,而幼稚性 Tregs 在培养结束时几乎消失。mRNA 分析显示,在培养期末,CD39、IL-10、颗粒酶 B 和 IL-35 水平显著升高(P<.05)。相反,IFNγ 的表达在第 14 天显著下降。根据 TIM3、CD39 和 CD62L 的表达水平对扩增的 Tregs 进行排序(纯度>95%)。当分析排序后的群体时,TIM3 细胞显著增加了 IL-10 和颗粒酶 B(P<.01)。当将扩增的 Tregs 输注到 NSG 小鼠模型中时,仅接受 Tcons 的小鼠死于 GVHD,而同时接受 Tcons 和 Tregs 的小鼠则无 GVHD 存活。使用全自动系统可以获得具有表型和功能 Treg 特征的 GMP 级扩增细胞。Treg 的抑制是通过多种重叠机制(例如 CTLA-4、CD39、IL-10、IL-35、TGF-β、颗粒酶 B)介导的。TIM3 细胞是一种具有潜在高度抑制作用的群体。